))
#6 - Immune checkpoint inhibitors, with Sandra Herrmann
Manage episode 399856240 series 3548026
Content provided by European Renal Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Renal Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
There’s a new kid on the block and he can bang up cancer cells very effectively, but, he doesn’t like to discriminate and won’t think a bit about roughing up the kidney as well. This kid has a fancy name – immune checkpoint inhibitor. Oncologists are raving about it, but nephrologists are freaking out about it. How do we solve this mess? Can cancer patients keep receiving these medications even if they have renal adverse events? And what about transplant patients? If you’ve wondered about this yourself, then you’re in luck because we’ll be asking these and similar relevant questions to Dr Sandra Herrmann, a well-known expert in the field of onco-nephrology.
36 episodes
Share
